SugenTech Intangible Assets

What does SugenTech do? SugenTech Inc. generates revenue through the manufacturing and sale of in vitro diagnostic test reagents, which are marketed under the brand SUREARLY for personal use. The company also sells point-of-care testing (POCT) products branded as INCLIX for professional use. Additionally, SugenTech offers folic acid products under the SOLGAR brand and molecular diagnostic reagents. The firm distributes these products domestically and to international markets such as Indonesia, targeting both individual consumers and healthcare professionals. Therapeutic drug monitoring and drug analysis method development services further contribute to the company's revenue streams. SOLGAR is the brand associated with folic acid products, while SUREARLY and INCLIX represent the diagnostic reagent and POCT product lines, respectively. The domestic market and Indonesia are key distribution channels for the company's offerings. Healthcare professionals utilize INCLIX for point-of-care testing, while individual consumers purchase SUREARLY for personal diagnostic needs. SugenTech's product portfolio includes both consumer-facing and professional medical solutions. The company's revenue model integrates the sale of diagnostic reagents, POCT products, and folic acid supplements, with SOLGAR, SUREARLY, and INCLIX serving as distinct product brands. Domestic and Indonesian markets are primary sales channels, catering to both end-users and healthcare providers. Therapeutic drug monitoring services complement the product sales, creating a diversified income stream from medical diagnostics and related services. SugenTech is one of the most popular companies on Eulerpool.